Moderate-intensity intermittent walking

Moderate-intensity intermittent walking has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 24, 2026: “Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled Study”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on moderate-intensity intermittent walking

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Significant improvements were observed in the TG group in liver enzymes alanine-transaminase (ALT), (p = 0.002, d = 0.29)”
Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled StudyEuropean journal of sport science2026doi:10.1002/ejsc.70147

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave moderate-intensity intermittent walking to people and measured what changed.

What changedDesignPeopleSource

down: Decreases alanine transaminasep = 0.002, d = 0.29

down: Decreases C-reactive proteinp = 0.007, d = 0.49

down: Decreases body massp < 0.001

Randomized trial10-week36 peopleWomenmean age 55.7 ± 3.5 yearsPostmenopausal women; sedentary postmenopausal women with obesityEuropean journal of sport science, Feb 24, 2026

What did studies of moderate-intensity intermittent walking find?

4

Studies of moderate-intensity intermittent walking measured 4 outcomes, among them aerobic capacity, body mass and C-reactive protein.

Aerobic capacity

upin humans1

1 study
  1. Moderate-intensity intermittent walking improves aerobic capacity in humans (sedentary postmenopausal women with obesity) (p = 0.031).

    “along with increased aerobic capacity (p = 0.031).”

    Human trialsedentary postmenopausal women with obesityMIWT protocol (4 sessions/week, ~85 min/session)10-weekfemalesn = 36

    Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled Study

    European journal of sport science

Body mass

downin humans1

1 study
  1. Moderate-intensity intermittent walking decreases body mass in humans (sedentary postmenopausal women with obesity) (p < 0.001).

    “Additionally, significant reductions were found in body mass (p < 0.001), BMI (p < 0.001), body fat (p = 0.001), and waist circumference (p < 0.001)”

    Human trialsedentary postmenopausal women with obesityMIWT protocol (4 sessions/week, ~85 min/session)10-weekfemalesn = 36

    Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled Study

    European journal of sport science

C-reactive protein

downin humans1

1 study
  1. Moderate-intensity intermittent walking decreases C-reactive protein in humans (sedentary postmenopausal women with obesity) (p = 0.007, d = 0.49).

    “C-reactive-protein (CRP) (p = 0.007, d = 0.49).”

    Human trialsedentary postmenopausal women with obesityMIWT protocol (4 sessions/week, ~85 min/session)10-weekfemalesn = 36

    Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled Study

    European journal of sport science

More on C-reactive protein

Alanine transaminase

downin humans1

1 study
  1. Moderate-intensity intermittent walking decreases alanine transaminase in humans (sedentary postmenopausal women with obesity) (p = 0.002, d = 0.29).

    “Significant improvements were observed in the TG group in liver enzymes alanine-transaminase (ALT), (p = 0.002, d = 0.29)”

    Human trialsedentary postmenopausal women with obesityMIWT protocol (4 sessions/week, ~85 min/session)10-weekfemalesn = 36

    Moderate-Intensity Intermittent Walking Improves Liver-Related Biomarkers and Reduces Inflammation in Postmenopausal Women With Obesity: A Randomized Controlled Study

    European journal of sport science

More on Alanine transaminase

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months